1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Drug Modelling Software Market – By Product Type

1.3.2        Asia Pacific Drug Modelling Software Market – By Application

1.3.3        Asia Pacific Drug Modelling Software Market – By Country

2.           Asia Pacific Drug Modelling Software Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Drug Modelling Software Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Drug Modelling Software Market - Asia Pacific PEST Analysis

4.3         Expert Opinion

5.           Asia Pacific Drug Modelling Software Market -  Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Increasing Adoption of Modelling Tools in Drug Discovery

5.1.2        Increasing Economic Burden of Drug Discovery

5.2         Key Market Restraints

5.2.1        Less Adoption in Emerging Countries

5.3         Key Market Opportunities

5.3.1        Strategic Activities by Market Players

5.4         Future Trends

5.4.1        Growing Adoption of Artificial Intelligence in Drug Discovery

5.5         Impact analysis

6.           Drug Modelling Software Market – Asia Pacific Analysis

6.1         Asia Pacific Drug Modelling Software Market Revenue Forecasts and Analysis

7.           Asia Pacific Drug Modelling Software Market Analysis and Forecasts To 2027 – By Product Type

7.1         Overview

7.2         Asia Pacific Drug Modelling Software Market, By Product Type 2019 & 2027 (%)

7.2.1        Asia Pacific Drug Modelling Software Market Revenue and Forecasts to 2027, By Product Type (US$ Mn)

7.3         Database

7.3.1        Overview

7.3.2        Asia Pacific Database Market Revenue and Forecast to 2027 (US$ Mn)

7.4         Software

7.4.1        Overview

7.4.1.1          Asia Pacific Software Revenue and Forecasts to 2027 (US$ Mn)

7.5         Other Product Types

7.5.1        Overview

7.5.2        Asia Pacific Other Product Types Market Revenue and Forecast to 2027 (US$ Mn)

8.           Asia Pacific Drug Modelling Software Market Analysis and Forecasts To 2027 – By Application

8.1         Overview

8.2         Asia Pacific Drug Modelling Software Market, By Application 2019 & 2027 (%)

8.2.1        Asia Pacific Drug Modelling Software Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3         Drug Discovery and Development

8.3.1        Overview

8.3.2        Asia Pacific Drug Discovery and Development Market Revenue and Forecast to 2027 (US$ Mn)

8.4         Computational Physiological Medicine

8.4.1        Overview

8.4.2        Asia Pacific Computational Physiological Medicine Market Revenue and Forecasts to 2027 (US$ Mn)

8.5         Disease Modelling

8.5.1        Overview

8.5.2        Asia Pacific Disease Modelling Market Revenue and Forecasts to 2027 (US$ Mn)

8.6         Medical Imaging

8.6.1        Overview

8.6.2        Asia Pacific Medical Imaging Market Revenue and Forecasts to 2027 (US$ Mn)

8.7         Predictive Analysis of Drug Targets

8.7.1        Overview

8.7.2        Asia Pacific Predictive Analysis of Drug Targets Market Revenue and Forecasts to 2027 (US$ Mn)

8.8         Simulation Software

8.8.1        Overview

8.8.2        Asia Pacific Simulation Software Market Revenue and Forecasts to 2027 (US$ Mn)

8.9         Cellular Simulation

8.9.1        Overview

8.9.2        Asia Pacific Cellular Simulation Market Revenue and Forecasts to 2027 (US$ Mn)

8.10      Others

8.10.1     Overview

8.10.2     Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

9.           Drug Modelling Software Market Revenue and Forecasts To 2027 – Geographical Analysis

9.1         Asia Pacific Drug modelling software Market Revenue and Forecasts To 2027

9.1.1        Overview

9.1.2        Asia-Pacific: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)

9.1.3        Asia-Pacific Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.4        Asia-Pacific Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.5        Asia-Pacific: Drug Modelling Software Market, by Country, 2019 & 2027 (%)

9.1.1        China: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.1.1          China: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.1.2          China Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.1.3          China Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.2        Japan: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.2.1          Japan: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.2.2          Japan Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.2.3          Japan Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.3        India: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.3.1          India: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.3.2          India Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.3.3          India Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.4        South Korea: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.4.1          South Korea: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.4.2          South Korea Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.4.3          South Korea Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.5        Australia: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.1          Australia: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.2          Australia Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.5.3          Australia Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.        Impact of COVID-19 Pandemic on Asia Pacific Drug Modelling Software Market

10.1      Asia Pacific: Impact Assessment of COVID-19 Pandemic

11.        Company Profiles

11.1      Genedata AG

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Biognos AB

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Dassault Systèmes

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Acellera

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.5      Crown Bioscience Inc (JSR life science)

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

12.        Appendix

12.1      About the Insight Partners

12.2      Glossary of Terms

LIST OF TABLES

Table 1.             Asia Pacific Drug Modelling Software Market Revenue and Forecasts To 2027, By Product Type (US$ Mn)

Table 2.             Asia Pacific Drug Modelling Software Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 3.             Asia-Pacific Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             Asia-Pacific Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5.             China Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             China Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 7.             Japan Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             Japan Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.             India Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 10.          India Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 11.          South Korea Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          South Korea Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 13.          Australia Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Australia Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.          Glossary of Terms, Drug Modelling Software Market

LIST OF FIGURES

Figure 1.           Drug Modelling Software Market Segmentation

Figure 2.           Asia Pacific Drug Modelling Software Market Overview

Figure 3.           Software Segment Held Largest Share of Drug Modelling Software Market

Figure 4.           India is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Asia Pacific Drug Modelling Software Market - Leading Country Markets (US$ Mn)

Figure 6.           Drug Modelling Software Market - Asia Pacific PEST Analysis

Figure 7.           Drug Modelling Software Market Impact Analysis of Driver and Restraints

Figure 8.           Asia Pacific Drug Modelling Software Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.           Asia Pacific Drug Modelling Software Market, By Product Type 2019 & 2027 (%)

Figure 10.        Asia Pacific Database Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        Asia Pacific Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        Asia Pacific Other Product Types Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        Asia Pacific Drug Modelling Software Market, By Application 2019 & 2027 (%)

Figure 14.        Asia Pacific Drug Discovery and Development Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        Asia Pacific Computational Physiological Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        Asia Pacific Disease Modelling Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        Asia Pacific Medical Imaging Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        Asia Pacific Predictive Analysis of Drug Targets Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        Asia Pacific Simulation Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        Asia Pacific Cellular Simulation Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        Asia-Pacific: Drug Modelling Software Market, by Key Country– Revenue (2019) (USD Million)

Figure 23.        Asia-Pacific Drug Modelling Software Market Revenue and Forecast to 2027 (USD Million)

Figure 24.        Asia-Pacific: Drug Modelling Software Market, by Country, 2019 & 2027 (%)

Figure 25.        China: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        Japan: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        India: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        South Korea: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Australia: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Impact of COVID-19 Pandemic In Asia Pacific Country Markets